Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia
NCT ID: NCT02936895
Last Updated: 2016-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2015-01-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some studies have shown that supplementing with vitamin D reduces disease of the respiratory tract infection. Some other studies have shown anti-inflammatory effect of vitamin D in cell lines. Studies about the role of vitamin D supplementation in pneumonia in children are inadequate to conclude about its role.
The aim of this study is to determine the efficacy of vitamin D supplementation in Respiratory Index of Severity in Children (RISC) hospitalized clinical outcomes of hospitalized patients with community-acquired pneumonia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin-D Supplementation: Impact on Severe Pneumonia Among Under-five Children
NCT02185196
Efficacy of Vitamin D Supplementation for Children With Bronchiolitis
NCT05795933
Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia?
NCT02802722
Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care.
NCT02617771
The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity
NCT02404623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3 (Low dose)
vitamin D at a dose of 50,000 IU per day for 2 days
Vitamin D3
vitamin D at a dose of 50,000 IU per day for 2 days
Placebo
Placebo (same size and shape) for 2 days
Placebo
Placebo for 2 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3
vitamin D at a dose of 50,000 IU per day for 2 days
Placebo
Placebo for 2 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Definite diagnosis of pneumonia
Exclusion Criteria
* Airway hypersensitivity or asthma
* allergies
* nasal polyps
* Using inhaled medications to one month prior to the study
* Receiving high doses of vitamin D
* Avoiding to complete informed consent form
2 Months
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hormozgan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hamidreza Mahboobi
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shahid Mohammadi hospital
Bandar Abbas, Hormozgan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.